Professor Manuel Espinoza is Associate Professor of the Division of Health Economics, Policy and Management in the School of Public Health. He holds a medical doctor degree and a MSc in Epidemiology, both from Pontificia Universidad Catolica de Chile; a MSc in Biostatistics from Universidad de Chile, a MSc in Health Economics and  PhD in Economics, both from University of York (UK). Before joining HKU, he was an Associate Professor at the School of Public Health, Pontificia Universidad Católica de Chile. During the last 15 years, Professor Espinoza has focused his academic work in the field of health technology assessment and health economics, particularly in economic evaluation and priority setting in health.

Professor Espinoza's research focuses on new methods for exploring heterogeneity and equity in economic evaluation, developing value frameworks for health decision making, policy impact analysis, and applied economic evaluation. He has been consultant for the World Bank, Intermarican Development Bank, United Nations Office of Project Services, and the Center for Global Development. Through this work he has contributed to the elaboration and update of health benefit plans in Argentina, Honduras, Dominican Republic, and Chile; to policy impact analysis in Belize and Chile, and implementing strategic purchasing for high cost technologies in Mexico and Chile.

He has also served scientific societies in different roles. He was Director of the Board of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR), President of the ISPOR Consortium LatinAmerica and co-editor of Value in Health, journal of ISPOR. Currently he is Editor-in-Chief of Value in Health Regional Issues and Chair of the Latin America Policy Forum of Health Technology Assessment International (HTAi).

1. Espinoza, MA, Zamorano, P., Zúñiga-San Martin, C., Taramasco, C., Martinez, F., Becerra, S., Letelier, M.J., Armijo, N. Improving efficiency in healthcare: lessons from successful health policies in Chile. Arc Med Res. 2025; 56(1):103105.
2. Botwright, S.,  Sittimart, M., Chavarina. KK., Bayani, DB., Merlin, T. Surgey, G., Suharlim, C.,  Espinoza, MA.,  Culyer, AJ., Oortwijn, W., Teerawattananon,. Y. Good Practices for Health Technology Assessment Guideline Development: A Report of the Health Technology Assessment International, HTAsiaLink, and ISPOR Special Task Force. 2025 Jan 6;40(1):e74.
3. Espinoza, MA., Severino, R., Balmaceda, C., Abbott, T., Cabieses B. The Socioeconomic Distribution of Life Expectancy and Healthy Life Expectancy in Chile. Int J Equity Health (2023)  22(1): 160
4. Zamorano, P., Espinoza, MA. Varela, T., Abbott, T., Tellez, A., Suarez, F., Armijo, N. Economic evaluation of a Multimorbidity patients centered care model implemented in the Chilean Public Health System. BMC Health Services Research. 2023.  23(1): 1041. (corresponding author)
5. Espinoza, MA., Abbott, A., Passi, A., Balmaceda, C. Health and economic effects on patients with Type 2 Diabetes Mellitus in the long run: Predictions for the Chilean population. Diabetology & Metabolic Syndrome (2022) 26;14(1):155.
6. Severino, R., Cabieses, B., Espinoza, MA. Health-related quality of life by household income in Chile: a concentration index decomposition analysis. Int J Equity Health (2022) 13;21(1):176 (corresponding author)
7. Terán, E., Gómez, H., Hannois, D., Lema, M., Mantilla, W., McElwee, E., Rico-Restrepo, M., Castro-Sanchez, N., Valdivieso, N. Espinoza, MA. Steamlining breast cancer and colorectal cancer biosimilar regulation to improve access in latinamerica: Expert Panel Perspective. Lancet Oncol 2022 23(7):e348-e358
8. Benkhalti, M., Espinoza, M., Cookson, R., Welch, V., Tugwell, P., Dagenais, P. Development of a checklist to guide equity considerations in health technology assessment. Int J Technology Assess Health Care (2021) 37: 1-8.
9. Espinoza, M.A., Claxton, K., Manca, A., Sculpher, M. Social value and individual choice: the value of a choice-based decision making process in a collectively funded health system. Health Economics 2018 Feb;27(2):e28-e40.
10. Espinoza, M. A., Manca, A., Claxton, K., Sculpher, M. The value of heterogeneity for cost-effectiveness subgroup analysis: Conceptual framework and application. 2014. Medical Decision Making 2014 Nov;34(8):951-64